U.S. Markets close in 2 hrs 33 mins

Zealand Pharma A/S (ZEAL.CO)

Copenhagen - Copenhagen Real Time Price. Currency in DKK
Add to watchlist
219.00-0.40 (-0.18%)
At close: 4:59PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close219.40
Open221.00
Bid218.80 x 0
Ask219.20 x 0
Day's Range218.20 - 223.80
52 Week Range125.20 - 297.20
Volume52,338
Avg. Volume153,472
Market Cap8.688B
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-17.76
Earnings DateMay 14, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est151.13
  • GlobeNewswire

    Zealand Pharma Expands U.S. Operations, Opens New Boston Office

    ·Commercial operations will be headquartered in Boston, as company looks to commercialize pipeline in the U.S. Copenhagen, DK and Boston, MA, U.S. July 6, 2020 – Zealand Pharma A/S (ZEAL.CO) (CVR-no. 20045078,) a biotechnology company changing lives with innovative peptide-based medicines, today announced the opening of its new U.S. headquarters in Boston which will be led by recently appointed President of Zealand Pharma U.S., Frank Sanders.

  • Zealand (ZEAL) Surges: Stock Moves 9.1% Higher
    Zacks

    Zealand (ZEAL) Surges: Stock Moves 9.1% Higher

    Zealand (ZEAL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

  • GlobeNewswire

    Total number of shares and voting rights in Zealand Pharma at June 30, 2020

    Zealand Pharma A/S (“Zealand”) (ZEAL.CO) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 32/2020 from June 12, 2020, Zealand announced an increase in share capital relating to the exercise of employee warrants, and in Company announcement No. 36/2020 from June 22, 2020, Zealand announced an increase in share capital relating to the completion of a private placement and directed issue of new shares.